My HPRA: Register

NUCALA

100 Milligram Pdr for Soln for Injection

GlaxoSmithKline Trading Services LimitedEU/1/15/1043/001-002

Main Information

Trade NameNUCALA
Active SubstancesMEPOLIZUMAB
Strength100 Milligram
Dosage FormPdr for Soln for Injection
Licence HolderGlaxoSmithKline Trading Services Limited
Licence NumberEU/1/15/1043/001-002

Group Information

ATC CodeR03DX OTHER ANTI-ASTHMATICS FOR SYSTEMIC USE

Status

Authorised/WithdrawnAuthorised
Licence Issued02/12/2015
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing Status--Unknown--
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back
Follow medicine

Print